IN2015DN02685A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02685A
IN2015DN02685A IN2685DEN2015A IN2015DN02685A IN 2015DN02685 A IN2015DN02685 A IN 2015DN02685A IN 2685DEN2015 A IN2685DEN2015 A IN 2685DEN2015A IN 2015DN02685 A IN2015DN02685 A IN 2015DN02685A
Authority
IN
India
Prior art keywords
subject
cancer
radiation
predisposition
copd
Prior art date
Application number
Inventor
Diana; Anderson
Mojgan; Jafzadeh
Morgan Clive Thomas; Denyer
Original Assignee
Univ Bradford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bradford filed Critical Univ Bradford
Publication of IN2015DN02685A publication Critical patent/IN2015DN02685A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7004—Stress
    • G01N2800/7009—Oxidative stress
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer

Abstract

The present invention relates to a method of determining the predisposition of a subject to cancer or other disease states characterised by free radical induced DNA damage such as COPD or asthma and identifying those with undiagnosed cancer. The method is able to utilise whole blood from a subject and is based on exposing the samples to different levels or intensities of electromagnetic radiation, preferably by altering the distance between the source of radiation and the sample.
IN2685DEN2015 2012-09-11 2013-09-10 IN2015DN02685A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1216174.1A GB201216174D0 (en) 2012-09-11 2012-09-11 Method of determining a predisposition to disease states characterised by free redical induced dna damage
PCT/GB2013/052365 WO2014041340A1 (en) 2012-09-11 2013-09-10 Methods of, and assay products for, determining the predisposition of a subject to disease states characterised by free radical induced dna damage

Publications (1)

Publication Number Publication Date
IN2015DN02685A true IN2015DN02685A (en) 2015-09-04

Family

ID=47137246

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2685DEN2015 IN2015DN02685A (en) 2012-09-11 2013-09-10

Country Status (7)

Country Link
US (1) US20150219619A1 (en)
EP (1) EP2895853A1 (en)
JP (1) JP2015529077A (en)
CN (1) CN104755927A (en)
GB (1) GB201216174D0 (en)
IN (1) IN2015DN02685A (en)
WO (1) WO2014041340A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9931634B2 (en) 2014-02-27 2018-04-03 The Regents Of The Univeristy Of California High throughput DNA damage quantification of human tissue with home-based collection device
EP4232821A1 (en) 2020-10-22 2023-08-30 4D Lifetec AG Dna damage sensitivity as a new biomarker for detection of cancer and cancer susceptibility

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1999274A2 (en) * 2006-03-02 2008-12-10 Laboratory Corporation of America Holdings Methods and systems for evaluating health risk factors by measurement of dna damage and dna repair

Also Published As

Publication number Publication date
GB201216174D0 (en) 2012-10-24
CN104755927A (en) 2015-07-01
WO2014041340A1 (en) 2014-03-20
JP2015529077A (en) 2015-10-05
EP2895853A1 (en) 2015-07-22
US20150219619A1 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
EA201590027A1 (en) DETECTION METHODS OF DISEASES OR CONDITIONS
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
WO2014144657A3 (en) Compositions and methods for cancer prognosis
WO2014028378A3 (en) Methods and systems for detecting biological components
EP3236262A3 (en) Surrogate functional diagnostics test for cancer
MX367366B (en) Compositions and methods for diagnosing thyroid tumors.
IL246060A0 (en) Biosensors for biological or chemical analysis and methods of manufacturing the same
WO2012021887A3 (en) Biomarkers for the early detection of breast cancer
MX2018008421A (en) Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies.
CL2013003433A1 (en) Method for analyzing a biological sample of a subject with cancer that comprises determining a level of expression of the biomarkers gli-1, otx-2, shroom2, pdlim3, and sphk1 in said sample, wherein the expression level of the biomarkers in co-operation With a control, it provides a diagnostic indicator of whether the subject has an increased probability of response to: a methyl-4'-trifluoromethoxy-biphenyl-3-carboxylic acid [6- (cis-2,6-dimethyl-morpholino-4 -yl) -pyridin-3-yl] -amide, or 2 - [(r) -4- (6-benzyl-4,5-dimethyl-pyridazin-3-yl) -2-methyl-3,4,5 , 6-tetrahydro-2h- [1,2 '] bipyrizanyl-5'-yl] -propan-2-ol; method for selecting a subject who has cancer for treatment with one of said compounds, which comprises determining the level of expression of shroom2 or sphk1, in a biological sample of the subject.
EP2576837A4 (en) Prostate cancer associated circulating nucleic acid biomarkers
WO2013107459A3 (en) Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples
EP4282405A3 (en) Detection of cancer biomarkers using nanoparticles
GB2526736A (en) Methods, compositions, and kits for nucleic acid analysis
MY182773A (en) Method for indicating a presence or non-presence of aggressive prostate cancer
WO2013172779A3 (en) Method for indicating the presence or non-presence of prostate cancer
WO2013190075A3 (en) Specific biomarkers for hepatocellular carcinoma (hcc)
MX358541B (en) Methods for predicting risk of developing hypertension.
EP4321866A3 (en) Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
MX2019010935A (en) Diagnostic gene marker panel for colorectal cancer.
MX357429B (en) Predictors for cancer treatment.
EP2738554A4 (en) Novel biological information processing and analysis method for identifying and quantifying n-glycopeptides
WO2015095862A3 (en) Microrna biomarkers for ovarian cancer
WO2015082416A8 (en) Novel rna-biomarkers for diagnosis of prostate cancer
WO2013124738A3 (en) Methods and biomarkers for detection and prognosis of cervical cancer